Cita APA

Borazanci, E., Schram, A. M., Garralda Cabanas, E., Braña Garcia, I., Vieito Villar, M., Spreafico, A., . . . Tabernero Caturla, J. (2022). Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors.

Citación estilo Chicago

Borazanci, Erkut, A. M. Schram, Elena Garralda Cabanas, Irene Braña Garcia, Maria Vieito Villar, A. Spreafico, Joan Seoane Suarez, y Josep Tabernero Caturla. Phase I, First-in-human Study of MSC-1 (AZD0171), a Humanized Anti-leukemia Inhibitory Factor Monoclonal Antibody, for Advanced Solid Tumors. 2022.

Cita MLA

Borazanci, Erkut, et al. Phase I, First-in-human Study of MSC-1 (AZD0171), a Humanized Anti-leukemia Inhibitory Factor Monoclonal Antibody, for Advanced Solid Tumors. 2022.